Mitzi Aguilar

1.0k total citations
15 papers, 646 citations indexed

About

Mitzi Aguilar is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Mitzi Aguilar has authored 15 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Mitzi Aguilar's work include Endometrial and Cervical Cancer Treatments (5 papers), Genetic factors in colorectal cancer (3 papers) and Ovarian cancer diagnosis and treatment (2 papers). Mitzi Aguilar is often cited by papers focused on Endometrial and Cervical Cancer Treatments (5 papers), Genetic factors in colorectal cancer (3 papers) and Ovarian cancer diagnosis and treatment (2 papers). Mitzi Aguilar collaborates with scholars based in United States, China and Japan. Mitzi Aguilar's co-authors include Huai‐Qiang Ju, Samir Hanash, Jie Fu, Paul J. Chiao, S. C. Tripathi, Herbert Levine, Mohit Kumar Jolly, Peng Huang, Takeshi Gocho and Katsuhiko Yanaga and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Cancer Research.

In The Last Decade

Mitzi Aguilar

15 papers receiving 640 citations

Peers

Countries citing papers authored by Mitzi Aguilar

Since Specialization

Citations

This map shows the geographic impact of Mitzi Aguilar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitzi Aguilar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitzi Aguilar more than expected).

Fields of papers citing papers by Mitzi Aguilar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitzi Aguilar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitzi Aguilar. The network helps show where Mitzi Aguilar may publish in the future.

Co-authorship network of co-authors of Mitzi Aguilar

This figure shows the co-authorship network connecting the top 25 collaborators of Mitzi Aguilar. A scholar is included among the top collaborators of Mitzi Aguilar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitzi Aguilar. Mitzi Aguilar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	β-catenin, PAX2, and PTEN Aberrancy Across the Spectrum of Endometrioid Ovarian Lesions 2024 ·International Journal of Gynecological Pathology ·(unknown), Mitzi Aguilar, Hao Chen, (unknown), Subhransu S. Sahoo, (unknown), Wenxin Zheng, Elena Lucas, Diego H. Castrillón	1
2	Utility of a PAX2, PTEN, and β-catenin Panel in the Diagnosis of Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia in Endometrial Polyps 2023 ·The American Journal of Surgical Pathology ·Elena Lucas, (unknown), Mitzi Aguilar, Kyle Molberg, Kelley Carrick, (unknown), Katja Gwin, Yan Wang, Wenxin Zheng, Diego H. Castrillón, Hao Chen	8
3	β-catenin, Pax2, and Pten Panel Identifies Precancers Among Histologically Subdiagnostic Endometrial Lesions 2023 ·The American Journal of Surgical Pathology ·Mitzi Aguilar, Hao Chen, Subhransu S. Sahoo, Wenxin Zheng, (unknown), Jeffrey A. SoRelle, Elena Lucas, Diego H. Castrillón	7
4	FOXA2 suppresses endometrial carcinogenesis and epithelial-mesenchymal transition by regulating enhancer activity 2022 ·Journal of Clinical Investigation ·Subhransu S. Sahoo, Susmita G. Ramanand, Yunpeng Gao, Ahmed K. Abbas, Ashwani Kumar, Ileana Cuevas, Hao‐Dong Li, Mitzi Aguilar, Chao Xing, Ram S. Mani, Diego H. Castrillón	15
5	Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies 2022 ·Modern Pathology ·Subhransu S. Sahoo, Mitzi Aguilar, Yan Xu, Elena Lucas, (unknown), Hao Chen, Wenxin Zheng, Ileana Cuevas, Hao‐Dong Li, (unknown), Megan Wachsmann, Justin A. Bishop, (unknown), Jeffrey Gagan, Prasad Koduru, Jeffrey A. SoRelle, Diego H. Castrillón	12
6	Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors 2021 ·The Journal of Pathology ·Mitzi Aguilar, He Zhang, (unknown), (unknown), Subhransu S. Sahoo, Hao‐Dong Li, Ileana Cuevas, Jayanthi Lea, David S. Miller, Hao Chen, Wenxin Zheng, Jeffrey Gagan, Elena Lucas, Diego H. Castrillón	16
7	A PoleP286R mouse model of endometrial cancer recapitulates high mutational burden and immunotherapy response 2020 ·JCI Insight ·Hao‐Dong Li, Changzheng Lu, He Zhang, Qing Hu, Junqiu Zhang, Ileana Cuevas, Subhransu S. Sahoo, Mitzi Aguilar, (unknown), Shanrong Zhang, Xiaojing Wang, Esra A. Akbay, Guo‐Min Li, Bo Li, Prasad Koduru, Peter Ly, Yang‐Xin Fu, Diego H. Castrillón	22
8	Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition 2019 ·Proceedings of the National Academy of Sciences ·Ileana Cuevas, Subhransu S. Sahoo, Vinod Kumar, He Zhang, Jill M. Westcott, Mitzi Aguilar, (unknown), Stephanie A. Sullivan, Chao Xing, D. Neil Hayes, Rolf A. Brekken, Victoria Bae‐Jump, Diego H. Castrillón	45
9	MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway 2017 ·Cancer Research ·S. C. Tripathi, Johannes F. Fahrmann, Müge Çeliktaş, Mitzi Aguilar, Kieren D. Marini, Mohit Kumar Jolly, Hiroyuki Katayama, Hong Wang, Eunice Murage, Jennifer B. Dennison, D. Neil Watkins, Herbert Levine, Edwin J. Ostrin, Ayumu Taguchi, Samir Hanash	85
10	NEMO peptide inhibits the growth of pancreatic ductal adenocarcinoma by blocking NF-κB activation 2017 ·Cancer Letters ·Zhuonan Zhuang, Hao Li, Harold Lee, Mitzi Aguilar, (unknown), Huai‐Qiang Ju, Tomonori Iida, Jianhua Ling, Jie Fu, Min Wu, Yi-Chen Sun, Lu Yu, Paul J. Chiao	6
11	Plasma-derived extracellular vesicle proteins as a source of biomarkers for lung adenocarcinoma 2017 ·Oncotarget ·Jody V. Vykoukal, Nan Sun, Clemente Aguilar-Bonavides, Hiroyuki Katayama, Ichidai Tanaka, Johannes F. Fahrmann, Michela Capello, Junya Fujimoto, Mitzi Aguilar, Ignacio I. Wistuba, Ayumu Taguchi, Edwin J. Ostrin, Samir Hanash	57
12	Numb prevents a complete epithelial–mesenchymal transition by modulating Notch signalling 2017 ·Journal of The Royal Society Interface ·Federico Bocci, Mohit Kumar Jolly, S. C. Tripathi, Mitzi Aguilar, Samir Hanash, Herbert Levine, José N. Onuchic	83
13	Redox Regulation of Stem-like Cells Though the CD44v-xCT Axis in Colorectal Cancer: Mechanisms and Therapeutic Implications 2016 ·Theranostics ·Huai‐Qiang Ju, Yun-Xin Lu, Dong-liang Chen, Tian Tian, Hai-Yu Mo, Xiao-Li Wei, (unknown), Feng Wang, Zhao-Lei Zeng, Hélène Pelicano, Mitzi Aguilar, Wei-Hua Jia, Rui‐Hua Xu	75
14	IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB Activation 2015 ·Clinical Cancer Research ·Zhuonan Zhuang, Huai‐Qiang Ju, Mitzi Aguilar, (unknown), Hao Li, Tomonori Iida, Harold Lee, (unknown), Haijun Zhou, Jianhua Ling, Zhongkui Li, Jie Fu, Min Wu, Min Li, Davide Melisi, Yoichiro Iwakura, Kesen Xu, Jason B. Fleming, Paul J. Chiao	95
15	Mechanisms of Overcoming Intrinsic Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma through the Redox Modulation 2014 ·Molecular Cancer Therapeutics ·Huai‐Qiang Ju, Takeshi Gocho, Mitzi Aguilar, Min Wu, (unknown), Jie Fu, Katsuhiko Yanaga, Peng Huang, Paul J. Chiao	119

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact